Close Menu

NEW YORK (GenomeWeb News) – Molecular Devices today announced a global distribution agreement with Fluxion Biosciences covering its IonFlux instruments and consumables.

Molecular Devices also is providing support for all IonFlux Systems users as part of the deal, it said.

Financial and other terms of the deal were not disclosed.

South San Francisco, Calif.-based Fluxion provides tools for cellular analysis. Its portfolio includes instruments for live cell imaging and the analysis of circulating tumor cells. The Ion Flux is for automated patch clamping.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Newsweek discusses the privacy issues raised by digital medicine.

A group of statisticians wants to eliminate researchers' reliance on 'statistical significance,' according to NPR.

In Nature this week: genetic analysis of Anatolian farmers, cotton genome analysis, and more.

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.